PharmiWeb.com - Global Pharma News & Resources
25-Apr-2019

Geratherm Medical AG: financial figures for 2018

DGAP-News: Geratherm Medical AG / Key word(s): Annual Results

25.04.2019 / 07:26
The issuer is solely responsible for the content of this announcement.


Corporate News

25th April 2019

Geratherm Medical releases financial figures for 2018

- Sales revenues 21.5 million EUR +2.3 %;

- Gross profit (EBITDA) 2,801 thousand EUR +58,4 %

- Operating profit (EBIT) 1,987 thousand EUR +216.9 %

- Result of ordinary business activities 1,478 thousand EUR +218.5 %

- Shareholders' earnings (EAT) 1,154 thousand EUR +69.7 %

- Earnings per share 23 cents (previous year 14 cents)

- Dividend proposal 40 cents per share, 12 cents

of which tax-neutral from the tax deposit account

- Investment phase in medical capillary production

completed, production started well

- Good business performance in 1st quarter and anticipated in 2019.


Geratherm Medical had a markedly better business performance in 2018 than in the previous year. Despite decommissioned capillary production, sales revenue rose slightly. The Healthcare Diagnostic segment, in which capillary production is integrated, posted a decline in sales of - 5.8 %. The segments Respiratory (+12.7 %), Medical Warming Systems (+20.7 %) and Cardio/Stroke (+23.2 %) all performed considerably better. The total group income of the shareholders of the parent company amounts to 1,684 thousand EUR (+53.8 %).

Good development prospects for the 2019 fiscal year.

Detailed information can be found in the published annual report at:

https://geratherm.com/geratherm/investor-relations/berichte/quartals-jahresberichte/ .

Yours sincerely

Geratherm Medical AG

Investor Relations

Geratherm Medical AG
Head office: Fahrenheitstraße 1, 98716 Geschwenda
Register court: Jena local court, HRB 111272
Executive board: Dr Gert Frank
Chair of supervisory board: Dipl.-Kfm. Rudolf Bröcker
Tel. 036205/98 0
E-Mail: info@geratherm.com
www.geratherm.com

Profile:
Geratherm Medical is an international medical technology company with the business segments Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke und Respiratory. Our roots lie in medical temperature measurement. In this area we offer a wide range of products, most of which have unique selling points. We provide our clients/patients with high-grade products from clinical thermometers through to complex warming systems for the OP and rescue sectors as well as MRI-capable incubators for newborns. In the field of Cardio we concentrate on product developments for the detection of atrial fibrillation to prevent strokes. The segment Respiratory is developing and marketing products for measuring pulmonary function. Geratherm has patented basic technologies in every significant business segment. We see ourselves as a researching medical technology company with a clear focus on products of medical diagnostics for generating vital data. Geratherm shares have been officially quoted on the Frankfurt Stock exchange since 2000 - in the soc-called prime standard. Further, Geratherm Medical is represented in the so-called German Entrepreneurial Index and German Healthcare Index.




Contact:
Dr. Gert Frank

25.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 803225

 
End of News DGAP News Service

Editor Details

Last Updated: 25-Apr-2019